Herbs & Supplements in Breast Cancer Usage, Impact, and Personalized Approaches for Diverse Populations

Launched by CASE COMPREHENSIVE CANCER CENTER · Apr 11, 2025

Keywords

ClinConnect Summary

This clinical trial is focused on understanding how people with breast cancer use herbs and supplements while they are undergoing treatment, like chemotherapy or hormone therapy. Researchers want to learn about the differences in these practices among patients at Cleveland Clinic locations in Florida and Ohio. To do this, they will ask participants to fill out a survey about their experiences with herbs and supplements.

To be eligible for this study, participants must be at least 18 years old and have been diagnosed with breast cancer at stages I, II, or III. They should also be currently receiving treatment and be under the care of a medical oncologist at the Cleveland Clinic. The study is not yet recruiting participants, but once it starts, individuals who qualify can expect to complete a one-time survey that helps researchers gather important information about their use of herbs and supplements during their cancer treatment.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age: 18 years and older.
• • Breast cancer diagnosis at pathologic stage (I, II, and III)
• • Participants with regional lymph node involvement
• • Received Chemotherapy and/ or Endocrine therapy
• • Established patients followed by a medical oncologist at Cleveland Clinic Florida and Ohio
• • Able and willing to participate in the one-time survey.
• Exclusion Criteria:
• • Under 18 years of age
• • Prior history of cancer diagnosis
• • Unable or unwilling to participate in the survey
• • Distant Metastatic Disease